Literature DB >> 29443220

Medical marijuana: Between a plant and a hard place.

David S Gloss1, Edward H Maa1.   

Abstract

Entities:  

Year:  2015        PMID： 29443220      PMCID： PMC5764472          DOI： 10.1212/CPJ.0000000000000159

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN： 2163-0402


× No keyword cloud information.
  9 in total

1.  Evaluation of a vaporizing device (Volcano) for the pulmonary administration of tetrahydrocannabinol.

Authors:  Arno Hazekamp; Renee Ruhaak; Lineke Zuurman; Joop van Gerven; Rob Verpoorte
Journal:  J Pharm Sci       Date:  2006-06       Impact factor: 3.534

Review 2.  Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.

Authors:  Orrin Devinsky; Maria Roberta Cilio; Helen Cross; Javier Fernandez-Ruiz; Jacqueline French; Charlotte Hill; Russell Katz; Vincenzo Di Marzo; Didier Jutras-Aswad; William George Notcutt; Jose Martinez-Orgado; Philip J Robson; Brian G Rohrback; Elizabeth Thiele; Benjamin Whalley; Daniel Friedman
Journal:  Epilepsia       Date:  2014-05-22       Impact factor: 5.864

3.  Evidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of Neurology.

Authors:  Melissa J Armstrong; Janis M Miyasaki
Journal:  Neurology       Date:  2012-07-18       Impact factor: 9.910

4.  Use of complementary and alternative medicine in an urban county hospital epilepsy clinic.

Authors:  B V McConnell; M Applegate; A Keniston; B Kluger; E H Maa
Journal:  Epilepsy Behav       Date:  2014-04-12       Impact factor: 2.937

5.  Human effects: an overview.

Authors:  R T Jones
Journal:  NIDA Res Monogr       Date:  1980

6.  Factors affecting theophylline clearances: age, tobacco, marijuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates, and ethanol.

Authors:  W J Jusko; M J Gardner; A Mangione; J J Schentag; J R Koup; J W Vance
Journal:  J Pharm Sci       Date:  1979-11       Impact factor: 3.534

Review 7.  Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology.

Authors:  Barbara S Koppel; John C M Brust; Terry Fife; Jeff Bronstein; Sarah Youssof; Gary Gronseth; David Gloss
Journal:  Neurology       Date:  2014-04-29       Impact factor: 9.910

8.  Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.

Authors:  Brenda E Porter; Catherine Jacobson
Journal:  Epilepsy Behav       Date:  2013-12       Impact factor: 2.937

9.  A controlled family study of cannabis users with and without psychosis.

Authors:  Ashley C Proal; Jerry Fleming; Juan A Galvez-Buccollini; Lynn E Delisi
Journal:  Schizophr Res       Date:  2013-12-02       Impact factor: 4.939
  9 in total
  2 in total

1.  Cannabinoid-Based Medicines and Multiple Sclerosis.

Authors:  Clementina Manera; Simone Bertini
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 2.  Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis.

Authors:  Francesca Gado; Maria Digiacomo; Marco Macchia; Simone Bertini; Clementina Manera
Journal:  Medicines (Basel)       Date:  2018-08-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.